Patents by Inventor Neena B. Haider

Neena B. Haider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11351225
    Abstract: The present invention relates to compositions and methods comprising administering gene modifiers for treating ocular disease.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: June 7, 2022
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventor: Neena B. Haider
  • Publication number: 20210123077
    Abstract: The present invention provides compositions and methods for treating an ocular condition and/or disease. In particular, compositions and methods of the invention are directed to a gene therapy for treatment of an ocular condition and/or disease. One particular aspect of the invention provides a recombinant DNA comprising (i) a therapeutic gene, a functional counterpart of a defective gene associated with manifestation said ocular condition or disease, or a combination thereof; and (ii) a delivery vehicle adapted for delivering said gene of (i) to cells in target ocular area for treating said ocular condition or disease, said delivery vehicle comprising an adeno-associated virus (AAV) serotype.
    Type: Application
    Filed: October 26, 2020
    Publication date: April 29, 2021
    Applicant: Ocugen, Inc.
    Inventors: Rasappa Arumugham, Arun Upadhyay, Neena B. Haider
  • Publication number: 20180271941
    Abstract: The present invention relates to compositions and methods comprising administering gene modifiers for treating ocular disease.
    Type: Application
    Filed: November 20, 2017
    Publication date: September 27, 2018
    Inventor: Neena B. Haider
  • Publication number: 20180251839
    Abstract: This application discloses compositions and methods for the diagnosis of retinal neovascularization.
    Type: Application
    Filed: October 12, 2017
    Publication date: September 6, 2018
    Inventor: Neena B. Haider
  • Patent number: 9855314
    Abstract: The present invention relates to compositions and methods comprising administering gene modifiers for treating ocular disease.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: January 2, 2018
    Assignee: The Schepens Eye Research Insititute, Inc.
    Inventor: Neena B. Haider
  • Publication number: 20160015783
    Abstract: The present invention relates to compositions and methods comprising administering gene modifiers for treating ocular disease.
    Type: Application
    Filed: March 3, 2014
    Publication date: January 21, 2016
    Inventor: Neena B. Haider
  • Publication number: 20150284798
    Abstract: This application discloses compositions and methods for the diagnosis of retinal neovascularization.
    Type: Application
    Filed: October 14, 2013
    Publication date: October 8, 2015
    Inventor: Neena B. Haider